{"id":"https://openalex.org/W2020495169","doi":"https://doi.org/10.4161/cc.20899","title":"Combined inhibition of Chk1 and Wee1: In vitro synergistic effect translates to tumor growth inhibition in vivo","display_name":"Combined inhibition of Chk1 and Wee1: In vitro synergistic effect translates to tumor growth inhibition in vivo","alternate_titles":[],"publication_year":2012,"publication_date":"2012-07-01","ids":{"openalex":"https://openalex.org/W2020495169","doi":"https://doi.org/10.4161/cc.20899","mag":"2020495169","pmid":"https://pubmed.ncbi.nlm.nih.gov/22713237"},"language":"en","primary_location":{"id":"doi:10.4161/cc.20899","doi":"https://doi.org/10.4161/cc.20899","is_oa":true,"landing_page_url":"https://doi.org/10.4161/cc.20899","pdf_url":"https://www.tandfonline.com/doi/pdf/10.4161/cc.20899?needAccess=true&role=button","source":{"id":"https://openalex.org/S86011449","display_name":"Cell Cycle","issn_l":"1551-4005","issn":["1551-4005","1538-4101"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","medline","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cell Cycle","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2020495169"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.tandfonline.com/doi/pdf/10.4161/cc.20899?needAccess=true&role=button","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5003221695","display_name":"Laura Carrassa","orcid":"https://orcid.org/0000-0003-2707-4301","observed_orcids":["https://orcid.org/0000-0003-2707-4301"]},"institutions":[{"id":"https://openalex.org/I19630809","display_name":"Mario Negri Institute for Pharmacological Research","ror":"https://ror.org/05aspc753","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I19630809","https://openalex.org/I4210110338","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Laura Carrassa","raw_affiliation_strings":["Laboratory of Molecular Pharmacology, Department of Oncology, Istituto di Ricerche Farmacologiche \"Mario Negri\", Milan, Italy. laura.carrassa@marionegri.it","Department of Oncology","Istituto di Ricerche Farmacologiche \u201cMario Negri","\u201d Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Molecular Pharmacology, Department of Oncology, Istituto di Ricerche Farmacologiche \"Mario Negri\", Milan, Italy. laura.carrassa@marionegri.it","institution_ids":["https://openalex.org/I19630809"]},{"raw_affiliation_string":"Department of Oncology","institution_ids":[]},{"raw_affiliation_string":"Istituto di Ricerche Farmacologiche \u201cMario Negri","institution_ids":["https://openalex.org/I19630809"]},{"raw_affiliation_string":"\u201d Milan, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027430576","display_name":"Rosaria Chil\u00e0","orcid":"https://orcid.org/0000-0003-1106-9591","observed_orcids":["https://orcid.org/0000-0003-1106-9591"]},"institutions":[{"id":"https://openalex.org/I19630809","display_name":"Mario Negri Institute for Pharmacological Research","ror":"https://ror.org/05aspc753","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I19630809","https://openalex.org/I4210110338","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Rosaria Chil\u00e0","raw_affiliation_strings":["Laboratory of Molecular Pharmacology; Department of Oncology; Istituto di Ricerche Farmacologiche \u201cMario Negri;\u201d Milan, Italy","Department of Oncology","Istituto di Ricerche Farmacologiche \u201cMario Negri","Laboratory of Molecular Pharmacology","\u201d Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Molecular Pharmacology; Department of Oncology; Istituto di Ricerche Farmacologiche \u201cMario Negri;\u201d Milan, Italy","institution_ids":["https://openalex.org/I19630809"]},{"raw_affiliation_string":"Department of Oncology","institution_ids":[]},{"raw_affiliation_string":"Istituto di Ricerche Farmacologiche \u201cMario Negri","institution_ids":["https://openalex.org/I19630809"]},{"raw_affiliation_string":"Laboratory of Molecular Pharmacology","institution_ids":[]},{"raw_affiliation_string":"\u201d Milan, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012186993","display_name":"Monica Lupi","orcid":"https://orcid.org/0000-0002-9835-7870","observed_orcids":["https://orcid.org/0000-0002-9835-7870"]},"institutions":[{"id":"https://openalex.org/I19630809","display_name":"Mario Negri Institute for Pharmacological Research","ror":"https://ror.org/05aspc753","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I19630809","https://openalex.org/I4210110338","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Monica Lupi","raw_affiliation_strings":["Laboratory of Cancer Pharmacology; Department of Oncology; Istituto di Ricerche Farmacologiche \u201cMario Negri;\u201d Milan, Italy","Department of Oncology","Istituto di Ricerche Farmacologiche \u201cMario Negri","Laboratory of Cancer Pharmacology","\u201d Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Cancer Pharmacology; Department of Oncology; Istituto di Ricerche Farmacologiche \u201cMario Negri;\u201d Milan, Italy","institution_ids":["https://openalex.org/I19630809"]},{"raw_affiliation_string":"Department of Oncology","institution_ids":[]},{"raw_affiliation_string":"Istituto di Ricerche Farmacologiche \u201cMario Negri","institution_ids":["https://openalex.org/I19630809"]},{"raw_affiliation_string":"Laboratory of Cancer Pharmacology","institution_ids":[]},{"raw_affiliation_string":"\u201d Milan, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023757905","display_name":"Francesca Ricci","orcid":"https://orcid.org/0000-0003-1705-186X","observed_orcids":["https://orcid.org/0000-0003-1705-186X"]},"institutions":[{"id":"https://openalex.org/I19630809","display_name":"Mario Negri Institute for Pharmacological Research","ror":"https://ror.org/05aspc753","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I19630809","https://openalex.org/I4210110338","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Francesca Ricci","raw_affiliation_strings":["Laboratory of Molecular Pharmacology; Department of Oncology; Istituto di Ricerche Farmacologiche \u201cMario Negri;\u201d Milan, Italy","Department of Oncology","Istituto di Ricerche Farmacologiche \u201cMario Negri","Laboratory of Molecular Pharmacology","\u201d Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Molecular Pharmacology; Department of Oncology; Istituto di Ricerche Farmacologiche \u201cMario Negri;\u201d Milan, Italy","institution_ids":["https://openalex.org/I19630809"]},{"raw_affiliation_string":"Department of Oncology","institution_ids":[]},{"raw_affiliation_string":"Istituto di Ricerche Farmacologiche \u201cMario Negri","institution_ids":["https://openalex.org/I19630809"]},{"raw_affiliation_string":"Laboratory of Molecular Pharmacology","institution_ids":[]},{"raw_affiliation_string":"\u201d Milan, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021361216","display_name":"Cinzia Celenza","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I19630809","display_name":"Mario Negri Institute for Pharmacological Research","ror":"https://ror.org/05aspc753","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I19630809","https://openalex.org/I4210110338","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Cinzia Celenza","raw_affiliation_strings":["Laboratory of Molecular Pharmacology; Department of Oncology; Istituto di Ricerche Farmacologiche \u201cMario Negri;\u201d Milan, Italy","Department of Oncology","Istituto di Ricerche Farmacologiche \u201cMario Negri","Laboratory of Molecular Pharmacology","\u201d Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Molecular Pharmacology; Department of Oncology; Istituto di Ricerche Farmacologiche \u201cMario Negri;\u201d Milan, Italy","institution_ids":["https://openalex.org/I19630809"]},{"raw_affiliation_string":"Department of Oncology","institution_ids":[]},{"raw_affiliation_string":"Istituto di Ricerche Farmacologiche \u201cMario Negri","institution_ids":["https://openalex.org/I19630809"]},{"raw_affiliation_string":"Laboratory of Molecular Pharmacology","institution_ids":[]},{"raw_affiliation_string":"\u201d Milan, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058567743","display_name":"Marco Mazzoletti","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I19630809","display_name":"Mario Negri Institute for Pharmacological Research","ror":"https://ror.org/05aspc753","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I19630809","https://openalex.org/I4210110338","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Marco Mazzoletti","raw_affiliation_strings":["Laboratory of Molecular Pharmacology; Department of Oncology; Istituto di Ricerche Farmacologiche \u201cMario Negri;\u201d Milan, Italy","Department of Oncology","Istituto di Ricerche Farmacologiche \u201cMario Negri","Laboratory of Molecular Pharmacology","\u201d Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Molecular Pharmacology; Department of Oncology; Istituto di Ricerche Farmacologiche \u201cMario Negri;\u201d Milan, Italy","institution_ids":["https://openalex.org/I19630809"]},{"raw_affiliation_string":"Department of Oncology","institution_ids":[]},{"raw_affiliation_string":"Istituto di Ricerche Farmacologiche \u201cMario Negri","institution_ids":["https://openalex.org/I19630809"]},{"raw_affiliation_string":"Laboratory of Molecular Pharmacology","institution_ids":[]},{"raw_affiliation_string":"\u201d Milan, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091714925","display_name":"Massimo Broggini","orcid":"https://orcid.org/0000-0002-8138-9358","observed_orcids":["https://orcid.org/0000-0002-8138-9358"]},"institutions":[{"id":"https://openalex.org/I19630809","display_name":"Mario Negri Institute for Pharmacological Research","ror":"https://ror.org/05aspc753","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I19630809","https://openalex.org/I4210110338","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Massimo Broggini","raw_affiliation_strings":["Laboratory of Molecular Pharmacology; Department of Oncology; Istituto di Ricerche Farmacologiche \u201cMario Negri;\u201d Milan, Italy","Department of Oncology","Istituto di Ricerche Farmacologiche \u201cMario Negri","Laboratory of Molecular Pharmacology","\u201d Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Molecular Pharmacology; Department of Oncology; Istituto di Ricerche Farmacologiche \u201cMario Negri;\u201d Milan, Italy","institution_ids":["https://openalex.org/I19630809"]},{"raw_affiliation_string":"Department of Oncology","institution_ids":[]},{"raw_affiliation_string":"Istituto di Ricerche Farmacologiche \u201cMario Negri","institution_ids":["https://openalex.org/I19630809"]},{"raw_affiliation_string":"Laboratory of Molecular Pharmacology","institution_ids":[]},{"raw_affiliation_string":"\u201d Milan, Italy","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5038885031","display_name":"Giovanna L.M. Damia","orcid":"https://orcid.org/0000-0001-9749-434X","observed_orcids":["https://orcid.org/0000-0001-9749-434X"]},"institutions":[{"id":"https://openalex.org/I19630809","display_name":"Mario Negri Institute for Pharmacological Research","ror":"https://ror.org/05aspc753","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I19630809","https://openalex.org/I4210110338","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Giovanna Damia","raw_affiliation_strings":["Laboratory of Molecular Pharmacology; Department of Oncology; Istituto di Ricerche Farmacologiche \u201cMario Negri;\u201d Milan, Italy","Department of Oncology","Istituto di Ricerche Farmacologiche \u201cMario Negri","Laboratory of Molecular Pharmacology","\u201d Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Molecular Pharmacology; Department of Oncology; Istituto di Ricerche Farmacologiche \u201cMario Negri;\u201d Milan, Italy","institution_ids":["https://openalex.org/I19630809"]},{"raw_affiliation_string":"Department of Oncology","institution_ids":[]},{"raw_affiliation_string":"Istituto di Ricerche Farmacologiche \u201cMario Negri","institution_ids":["https://openalex.org/I19630809"]},{"raw_affiliation_string":"Laboratory of Molecular Pharmacology","institution_ids":[]},{"raw_affiliation_string":"\u201d Milan, Italy","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5003221695"],"corresponding_institution_ids":["https://openalex.org/I19630809"],"apc_list":null,"apc_paid":null,"fwci":4.5049,"has_fulltext":true,"cited_by_count":125,"citation_normalized_percentile":{"value":0.96370706,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":100},"biblio":{"volume":"11","issue":"13","first_page":"2507","last_page":"2517"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10123","display_name":"DNA Repair Mechanisms","score":0.5634999871253967,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10123","display_name":"DNA Repair Mechanisms","score":0.5634999871253967,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.2996000051498413,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10492","display_name":"Microtubule and mitosis dynamics","score":0.03370000049471855,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chk1-inhibition","display_name":"CHK1 inhibition","score":0.8629999756813049},{"id":"https://openalex.org/keywords/wee1-inhibition","display_name":"WEE1 inhibition","score":0.9980000257492065},{"id":"https://openalex.org/keywords/synthetic-lethality","display_name":"synthetic lethality","score":0.8840000033378601},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7279999852180481},{"id":"https://openalex.org/keywords/mk-1775","display_name":"MK-1775","score":0.996999979019165},{"id":"https://openalex.org/keywords/ovarian-cancer","display_name":"ovarian cancer","score":0.5479999780654907},{"id":"https://openalex.org/keywords/premature-mitosis","display_name":"premature mitosis","score":0.8330000042915344},{"id":"https://openalex.org/keywords/dna-damage","display_name":"DNA damage","score":0.6639999747276306},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.984000027179718},{"id":"https://openalex.org/keywords/p53-independent","display_name":"p53-independent","score":0.734000027179718},{"id":"https://openalex.org/keywords/protein-kinase-inhibitors","display_name":"protein kinase inhibitors","score":0.5460000038146973},{"id":"https://openalex.org/keywords/tumor-growth-inhibition","display_name":"tumor growth inhibition","score":0.9279999732971191}],"concepts":[{"id":"https://openalex.org/C2781252693","wikidata":"https://www.wikidata.org/wiki/Q7979264","display_name":"Wee1","level":5,"score":0.9365454912185669},{"id":"https://openalex.org/C50001416","wikidata":"https://www.wikidata.org/wiki/Q17861750","display_name":"CHEK1","level":5,"score":0.8070493340492249},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.783409059047699},{"id":"https://openalex.org/C2778502085","wikidata":"https://www.wikidata.org/wiki/Q7662767","display_name":"Synthetic lethality","level":4,"score":0.6879404187202454},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6690912246704102},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.5090210437774658},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.49226680397987366},{"id":"https://openalex.org/C143425029","wikidata":"https://www.wikidata.org/wiki/Q5205747","display_name":"DNA damage","level":3,"score":0.4752647280693054},{"id":"https://openalex.org/C186000732","wikidata":"https://www.wikidata.org/wiki/Q6881914","display_name":"Mitotic catastrophe","level":4,"score":0.46992790699005127},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.45303237438201904},{"id":"https://openalex.org/C93304396","wikidata":"https://www.wikidata.org/wiki/Q14763008","display_name":"Mitosis","level":2,"score":0.4524877369403839},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.441064715385437},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.4277578294277191},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.4175008535385132},{"id":"https://openalex.org/C134935766","wikidata":"https://www.wikidata.org/wiki/Q210538","display_name":"DNA repair","level":3,"score":0.3843437731266022},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.2669029235839844},{"id":"https://openalex.org/C105696609","wikidata":"https://www.wikidata.org/wiki/Q1068809","display_name":"Cell cycle checkpoint","level":4,"score":0.2554381489753723},{"id":"https://openalex.org/C120504264","wikidata":"https://www.wikidata.org/wiki/Q1147372","display_name":"Cyclin-dependent kinase 1","level":4,"score":0.17877447605133057},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.15633997321128845},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.14121350646018982}],"mesh":[{"descriptor_ui":"D000071877","descriptor_name":"Checkpoint Kinase 1","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001570","descriptor_name":"Benzodiazepinones","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D001570","descriptor_name":"Benzodiazepinones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004261","descriptor_name":"DNA Replication","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008819","descriptor_name":"Mice, Nude","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008938","descriptor_name":"Mitosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D009687","descriptor_name":"Nuclear Proteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D009687","descriptor_name":"Nuclear Proteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D009687","descriptor_name":"Nuclear Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D011494","descriptor_name":"Protein Kinases","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D011494","descriptor_name":"Protein Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D011494","descriptor_name":"Protein Kinases","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D011505","descriptor_name":"Protein-Tyrosine Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D011505","descriptor_name":"Protein-Tyrosine Kinases","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D011505","descriptor_name":"Protein-Tyrosine Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011744","descriptor_name":"Pyrimidinones","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014183","descriptor_name":"Transplantation, Heterologous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D018797","descriptor_name":"Cell Cycle Proteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D018797","descriptor_name":"Cell Cycle Proteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D018797","descriptor_name":"Cell Cycle Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D034622","descriptor_name":"RNA Interference","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D034741","descriptor_name":"RNA, Small Interfering","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.4161/cc.20899","doi":"https://doi.org/10.4161/cc.20899","is_oa":true,"landing_page_url":"https://doi.org/10.4161/cc.20899","pdf_url":"https://www.tandfonline.com/doi/pdf/10.4161/cc.20899?needAccess=true&role=button","source":{"id":"https://openalex.org/S86011449","display_name":"Cell Cycle","issn_l":"1551-4005","issn":["1551-4005","1538-4101"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","medline","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cell Cycle","raw_type":"journal-article"},{"id":"pmid:22713237","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22713237","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cell cycle (Georgetown, Tex.)","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.4161/cc.20899","doi":"https://doi.org/10.4161/cc.20899","is_oa":true,"landing_page_url":"https://doi.org/10.4161/cc.20899","pdf_url":"https://www.tandfonline.com/doi/pdf/10.4161/cc.20899?needAccess=true&role=button","source":{"id":"https://openalex.org/S86011449","display_name":"Cell Cycle","issn_l":"1551-4005","issn":["1551-4005","1538-4101"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","medline","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cell Cycle","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2020495169.pdf","grobid_xml":"https://content.openalex.org/works/W2020495169.grobid-xml"},"referenced_works_count":48,"referenced_works":["https://openalex.org/W163730063","https://openalex.org/W1485263743","https://openalex.org/W1524628399","https://openalex.org/W1606320443","https://openalex.org/W1752089945","https://openalex.org/W1840165714","https://openalex.org/W1974327959","https://openalex.org/W1996799079","https://openalex.org/W2003884609","https://openalex.org/W2005873123","https://openalex.org/W2006220656","https://openalex.org/W2008401436","https://openalex.org/W2017289276","https://openalex.org/W2023942118","https://openalex.org/W2026946172","https://openalex.org/W2030646897","https://openalex.org/W2035263093","https://openalex.org/W2037752008","https://openalex.org/W2040640949","https://openalex.org/W2050072146","https://openalex.org/W2059084973","https://openalex.org/W2068643937","https://openalex.org/W2072763778","https://openalex.org/W2076314401","https://openalex.org/W2083101590","https://openalex.org/W2083225541","https://openalex.org/W2086255242","https://openalex.org/W2086333179","https://openalex.org/W2086377914","https://openalex.org/W2089190410","https://openalex.org/W2090658325","https://openalex.org/W2092308103","https://openalex.org/W2101173071","https://openalex.org/W2113684644","https://openalex.org/W2114778334","https://openalex.org/W2115694409","https://openalex.org/W2116964110","https://openalex.org/W2127136362","https://openalex.org/W2130184067","https://openalex.org/W2135946515","https://openalex.org/W2136277289","https://openalex.org/W2144455387","https://openalex.org/W2151918127","https://openalex.org/W2160738354","https://openalex.org/W2161171953","https://openalex.org/W2161480083","https://openalex.org/W4235541467","https://openalex.org/W6677219769"],"related_works":["https://openalex.org/W2026041809","https://openalex.org/W2323471842","https://openalex.org/W2090658325","https://openalex.org/W2317240129","https://openalex.org/W2133150002","https://openalex.org/W2561436545","https://openalex.org/W2083101590","https://openalex.org/W2740347007","https://openalex.org/W2327485242","https://openalex.org/W3009578478"],"abstract_inverted_index":{"Targeting":[0],"Chk1":[1,19,28,77,98,168,204],"protein":[2,65],"kinase":[3,81],"can":[4],"enhance":[5],"the":[6,68,83,107,123,131,141,165,180,196,200],"antitumor":[7],"effects":[8],"of":[9,18,96,122,143,159,167,199,202],"radio-":[10],"and":[11,24,101,169,205],"chemotherapy.":[12],"Recent":[13],"evidence":[14],"disclosed":[15],"a":[16,40,54,58,97,102,192,203,206],"role":[17],"in":[20,37,47,67,87,111],"unperturbed":[21],"cell":[22,72,115,151],"proliferation":[23],"survival,":[25],"implying":[26],"that":[27,130],"inhibitors":[29,171,181],"could":[30],"also":[31],"be":[32],"effective":[33],"as":[34,183],"single":[35,184],"agents":[36,185],"tumors":[38],"with":[39,50,90,93,146,164,179,186],"specific":[41],"genetic":[42],"background.":[43],"To":[44],"identify":[45],"genes":[46],"synthetic":[48,88],"lethality":[49,89],"Chk1,":[51],"we":[52],"did":[53],"high-throughput":[55],"screening":[56],"using":[57],"siRNA":[59],"library":[60],"directed":[61],"against":[62],"719":[63],"human":[64,69,113],"kinases":[66],"ovarian":[70],"cancer":[71,114,134],"line":[73],"OVCAR-5,":[74],"resistant":[75],"to":[76,136,150,173],"inhibitors.":[78],"Wee1":[79,103,170,207],"tyrosine":[80],"was":[82],"most":[84],"significant":[85],"gene":[86],"Chk1.":[91],"Treatment":[92],"non-toxic":[94],"concentrations":[95],"inhibitor":[99,104],"(PF-00477736)":[100],"(MK-1775)":[105],"confirmed":[106],"marked":[108],"synergistic":[109],"effect":[110],"various":[112],"lines":[116],"(breast,":[117],"ovarian,":[118],"colon,":[119],"prostate),":[120],"independently":[121],"p53":[124],"status.":[125],"Detailed":[126],"molecular":[127],"analysis":[128],"showed":[129],"combination":[132,166,201],"caused":[133],"cells":[135],"undergo":[137],"premature":[138],"mitosis":[139],"before":[140],"end":[142],"DNA":[144,148],"replication,":[145],"damaged":[147],"leading":[149],"death":[152],"partly":[153],"by":[154],"apoptosis.":[155],"In":[156],"vivo":[157],"treatment":[158],"mice":[160],"bearing":[161],"OVCAR-5":[162],"xenografts":[163],"led":[172],"greater":[174],"tumor":[175],"growth":[176],"inhibition":[177],"than":[178],"used":[182],"no":[187],"toxicity.":[188],"These":[189],"data":[190],"provide":[191],"strong":[193],"rationale":[194],"for":[195],"clinical":[197],"investigation":[198],"inhibitor.":[208]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2020495169","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":8},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":8},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":8},{"year":2018,"cited_by_count":14},{"year":2017,"cited_by_count":8},{"year":2016,"cited_by_count":15},{"year":2015,"cited_by_count":16},{"year":2014,"cited_by_count":11},{"year":2013,"cited_by_count":12},{"year":2012,"cited_by_count":7}],"updated_date":"2026-11-19T14:11:59.513116","created_date":"2016-06-24T00:00:00"}
